Answer
Lipidem’s long-chain omega-3 polyunsaturated fatty acids are precursors of anti-inflammatory eicosanoids, reducing pro-inflammatory cytokine production from arachidonic acid and increasing anti-inflammatory cytokine production from eicosapentaenoic and docosahexaenoic acids, which may benefit patients at risk of a hyperinflammatory state and sepsis.
Sources for this answer
- Lipidem 200 mg/ml emulsion for infusionB.Braun Medical · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked